FDA clears Integra's collagen nerve guide:
This article was originally published in Clinica
Executive Summary
Integra LifeSciences (Plainsboro, New Jersey) has received US FDA 510(k) clearance to market its absorbable implant for repairing severed peripheral nerves in the extremities. The NeuraGen nerve guide consists of a collagen tube that provides both a protective environment for the regenerating nerve and a conduit through which regenerating axons can bridge an injury. The firm plans to launch the product through its Integra NeuroSciences division later this year. It also intends to CE-mark the device for sale in Europe and is working with its partner, Century Medical, to gain market approval in Japan.
You may also be interested in...
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.